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Abstract
Neurodevelopmental abnormalities in neural connectivity have been long implicated in the etiology of schizophrenia
(SCZ); however, it remains unclear whether these neural connectivity patterns are associated with genetic risk for SCZ
in unaffected individuals (i.e., an absence of clinical features of SCZ or a family history of SCZ). We examine whether
polygenic risk scores (PRS) for SCZ are associated with functional neural connectivity in adolescents and young adults
without SCZ, whether this association is moderated by sex and age, and if similar associations are observed for
genetically related neuropsychiatric PRS. One-thousand four-hundred twenty-six offspring from 913 families,
unaffected with SCZ, were drawn from the Collaborative Study of the Genetics of Alcoholism (COGA) prospective
cohort (median age at ﬁrst interview = 15.6 (12–26), 51.6% female, 98.1% European American, 41% with a family
history of alcohol dependence). Participants were followed longitudinally with resting-state EEG connectivity (i.e.,
coherence) assessed every two years. Higher SCZ PRS were associated with elevated theta (3–7 Hz) and alpha
(7–12 Hz) EEG coherence. Associations differed by sex and age; the most robust associations were observed between
PRS and parietal-occipital, central-parietal, and frontal-parietal alpha coherence among males between ages 15–19 (B:
0.15–0.21, p < 10–4). Signiﬁcant associations among EEG coherence and Bipolar and Depression PRS were observed,
but differed from SCZ PRS in terms of sex, age, and topography. Findings reveal that polygenic risk for SCZ is robustly
associated with increased functional neural connectivity among young adults without a SCZ diagnosis. Striking
differences were observed between men and women throughout development, mapping onto key periods of risk for
the onset of psychotic illness and underlining the critical importance of examining sex differences in associations with
neuropsychiatric PRS across development.
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Schizophrenia (SCZ) is a debilitating neuropsychiatric
syndrome with typical onset during the second decade of
life, and characterized by pronounced deﬁcits in sensory
and cognitive processing1. Hypotheses regarding its neurodevelopmental origins date back to Kraepelin, and later
studies of high-risk children describe neurological “dysmaturation” during early childhood2. Genetic risk for
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SCZ, as measured by polygenic risk scores (PRS), and
brain functional connectivity have been studied among
those affected with SCZ3–5. However, investigating neurodevelopmental patterns of connectivity in unaffected
adolescents and young adults, at varying levels of polygenic susceptibility, may uncover basic patterns of brain
connectivity that could underlie development of the disorder. This information can elucidate basic neurobiological mechanisms by which the variants that contribute to
genetic risk for SCZ affect brain connectivity and development patterns.
Disordered cortical connectivity is now considered a
central feature of SCZ, with evidence from human and
animal studies demonstrating structural and functional
dysconnectivity between several brain regions6–8. Neural
functional connectivity measured using EEG has the
advantage of temporal resolution on the order of milliseconds, the scale at which most relevant sensory, motor
and cognitive phenomena occur8. EEG coherence measures functional connectivity by the degree of synchrony in
oscillatory activity between two brain regions, with
increased coherence indicating functional integration
between these brain regions and decreased coherence
reﬂecting less correlated neural activity9,10. Stated another
way, EEG coherence reﬂects communication between distinct brain regions, which facilitate cognition and behavior11–14. Either extreme of this spectrum may indicate
disturbances in neural interactions underlying cognition,
particularly in the absence of task-related activity (e.g.,
Default Mode Network15,16). Differences in resting-state
EEG coherence have been observed in individuals with
SCZ and in their relatives5, with studies most consistently
showing increases in intrahemispheric and interhemispheric coherence in the theta (3–7 Hz), alpha (7–12 Hz)
frequencies5, among mixed evidence of mis-connectivity
among affected individuals7,17,18. We note that differences
in other frequency bands, including the gamma frequency
(28–50 Hz) have been reported for spectral power and
other aspects of EEG. These inconsistent results may result
from small and heterogenous samples, since neural connectivity changes dynamically across the lifespan19, with
relatively random network structures in childhood changing to more ordered networks in adolescence and emerging adulthood20. For these reasons, coherence has been
particularly useful in the study of normal brain development and neuropsychiatric traits17,21, and in genomic studies of neurodevelopment and mental health conditions22.
However, few studies have focused on neurodevelopmental
trajectories among adolescents and young adults, some of
whom may be prior to their onset of SCZ, but the vast
majority of whom will remain unaffected. Such study
designs allow a prospective view of future illness but are
also relatively uncontaminated by neurobiological sequelae
of the illness or its treatment.
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The past decade has seen immense progress in psychiatric genetics, with genome-wide association studies
(GWAS) having now identiﬁed 245 distinct risk loci for
SCZ and the demonstration of polygenic inﬂuences on
SCZ3,4. Polygenic risk scores (PRS) aggregate genetic
information from large GWAS3, and index individuals’
polygenic liability for a given trait or disorder in an
independent sample. Recent studies have shown that
polygenic risk for SCZ inﬂuences aspects of executive
functioning in individuals with23 and without SCZ24,
albeit with limited effect sizes. By harnessing the polygenicity underlying SCZ and genetically correlated disorders (e.g., Bipolar Disorder (BiP) and Major Depressive
Disorder (MDD)25), PRS can be leveraged to enhance our
understanding of how genetic vulnerability to SCZ may
manifest as individual differences in brain activity, providing critical interpretative context for emergent GWAS
ﬁndings. Large GWAS have demonstrated, using PRS and
genome-wide correlations, that there are considerable
pleiotropic effects underlying SCZ, bipolar disorder (BiP),
and major depressive disorder (MDD)25. By contrasting
the SCZ PRS with PRS for genetically correlated disorders, such as BiP and MDD, the speciﬁcity and commonality of these genetic vulnerabilities on brain activity
can be estimated. Although a previous study reported no
association between SCZ PRS and classical EEG endophenotypes (e.g., P3 amplitude)26, no study has examined
the inﬂuence of SCZ PRS on EEG connectivity in unaffected individuals. Further, no study has examined how
these associations may differ by sex or across adolescence
and young adulthood, the time-frame during which SCZ
typically manifests. This is important, given research
demonstrating sex and developmental differences in
measures of EEG coherence27,28, the clinical presentation
of SCZ29, and polygenic effects on neuropsychiatric
illnesses22,30,31.
In the current study, we seek to uncover neurodevelopmental patterns of brain connectivity in unaffected
(with SCZ, BiP, or MDD) adolescents and young adults as
a function of their polygenic susceptibility for SCZ. We
also aim to understand important sex and developmental
differences in these brain connectivity patterns. We
examined associations between polygenic risk for SCZ32
and neurodevelopmental trajectories of EEG coherence
throughout adolescence and young adulthood among
unaffected (nonpsychotic) individuals. Data was drawn
from the Collaborative Study on the Genetics of Alcoholism (COGA), with longitudinal data available
throughout a key period of risk for the onset of psychotic
illness, ages 12–32. We also examined sex-speciﬁc effects
and developmental differences in the association of SCZ
PRS and EEG coherence that may be otherwise masked.
Finally, we examined whether PRS for genetically correlated neuropsychiatric conditions, BiP and MDD, were

Meyers et al. Translational Psychiatry (2021)11:54

differentially associated with neurodevelopmental trajectories of connectivity.

Methods
Sample and measures

COGA’s prospective study began data collection in 2004
and ended in 2019. Details of data collection and procedures have been published33. Brieﬂy, offspring from
families affected with AUD and community comparison
families from the COGA study were enrolled when they
were aged 12–22, with new subjects added as they reached
the age of 12. Subjects were assessed ~every 2 years with a
comprehensive battery that includes the Semi-Structured
Assessment for the Genetics of Alcoholism (SSAGA)34,35
assessing substance use and related disorders, neurocognitive performance, and a neurophysiological battery that
includes resting-state EEG. Owing to the majority European ancestry (EA) of the PGC SCZ GWAS, our analytic
sample comprises EA individuals with genotypic and EEG
data from at least three assessments (N = 1426 offspring
from 913 EA families, with a mean of 3.5 assessments).
Among them, the median age at ﬁrst interview was 15.6
(Range = 12–26), 51.6% were female, 17.8% met criteria
for DSM-IV Alcohol Dependence, and 41% had a family
history of AUD. Experimental protocols were approved by
each site’s IRB, and informed consent was obtained from
all participants, including parental permission from participants aged 18 years or younger.
EEG recording and processing have been detailed previously36. Brieﬂy, resting (eyes-closed) EEG was recorded
for 4.25 min; a continuous interval of 256 seconds was
analyzed. Each subject wore a ﬁtted electrode cap using
the 64-channel montage as speciﬁed according to the
10–20 International system. The nose served as reference
and the ground electrode was placed on the forehead.
Electrode impedances were always maintained below 5
KOhm. EEG was recorded with subjects seated comfortably in a dimly lit sound-attenuated temperature-regulated booth. They were instructed to keep their eyes
closed and remain relaxed, but not to fall asleep. Electrical
activity was ampliﬁed 10,000 times by Neuroscan ampliﬁers, with a bandpass between 0.02 Hz and 100 Hz and
recorded using the Neuroscan system (Compumedics
Limited; El Paso, TX). EEG procedures were identical at
all collection sites. Bipolar electrode pairs were derived to
reduce volume conduction effects, and 27 representative
coherence pairs (depicted in Fig. 1) were selected based on
previous EEG coherence work in COGA36. Conventional
Fourier transform methods37 were used to calculate
coherence. Coherence measures were generated at the
following frequencies: theta (3–7 Hz), alpha (7–12 Hz),
beta (12–28 Hz).
Genotyping for the COGA EA participants was performed in batches using the Illumina 1 M, Illumina

Page 3 of 11

OmniExpress, Illumina 2.5 M, and Smokescreen arrays.
Details have previously been reported38. Brieﬂy, a pruned
set of 47,000 variants that were genotyped on all platforms
and had minor allele frequencies >10% in the combined
samples, Hardy–Weinberg equilibrium (HWE) p-values >
0.001, missing rates <2%, and were not in linkage disequilibrium (LD; deﬁned as R2 < 0.5) were used to assess
reported pedigree structure using identity-by-descent
calculations in PLINK39. Family structures were altered
as needed and SNP genotypes were tested for Mendelian
inconsistencies with the revised family structure40. Genotype inconsistencies were set to missing. Imputation was
to 1000 Genomes (EUR and AFR, Phase 3, b37, October
2014; build hg19) using SHAPEIT241 and then Minimac342. Imputed SNPs with INFO scores <0.30 or individual genotype probability <0.90 were excluded, as were
palindromic SNPs, monomorphic SNPs, SNPs with a
genotyping rate of <95%, SNPs that were not in HWE, and
SNPs with a minor allele frequency <0.05%. In total,
6,881,872 SNPs passed quality control and were available
for analysis.
Polygenic risk scores (PRS) were constructed using the
results published PGC GWAS of SCZ (36,989 cases and
113,075 controls)32, BiP (20,352 cases and 31,358 controls)43, and MDD (135,458 cases and 344,901 controls)44.
To obtain independent sets of SNPs, we performed linkage disequilibrium (LD) based “clumping” in the COGA
EA sample (founders only) using a 500 kb physical distance and an LD threshold of r2 ≥ 0.1. For each COGA
participant, we derived an individual-level risk score by
weighting the number of risk alleles at each independent
SNP by the natural logarithm of its odds ratio (OR) and
summing this quantity across independent SNPs. scores
based on nine progressively more inclusive thresholds of
statistical signiﬁcance in each discovery GWAS: p <
0.0001, 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5. To aid
in the interpretation, PRS values were transformed to Zscores so that effect sizes could be expressed as SD of
coherence values per SD of PRS.
Statistical analysis

We examined the trajectory of association among SCZ
PRS with EEG coherence (theta, alpha, and beta). Association trajectories of PRS with EEG coherence were
calculated as described in detail previously22,28. Given
previous research demonstrating sex differences both in
measures of EEG28, the clinical presentation of SCZ29, and
polygenic effects on neuropsychiatric illnesses22,30,31, sexspeciﬁc models were examined. Covariates in the model
included genotyping array, ancestral principal components (PCs 1–3), and a sex × PRS interaction term.
Weights for individuals were adjusted to account for
multiple observations on single individuals and copresence of related individuals (e.g., siblings). Given the
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Fig. 1 Scalp topography of EEG electrodes used for the computation of coherence. The schematic represents a top view of the scalp, nose up.
Coherence (solid lines) was computed between bipolar EEG signals, each of which was derived from a pair of adjacent electrodes (connected by
dotted lines). Electrode labeling: letters F, C, T, P, and O represent frontal, central, temporal, parietal, and occipital areas of the scalp, respectively; odd
and even numbers represent the left and right hemispheres, respectively, and “Z” denotes electrodes along the sagittal midline. 27 Coherences
between bipolar electrode pairs are illustrated as follows: frontal-central sagittal coherences are represented in blue; (1) F8-T8--F7-T7, (2) F4-C4--F3-C3,
(3) F3-C3--F8-T8, (4) F4-C4--F7-T7, (5) F3-C3--F7-T7, (6) F4-C4--F8-T8, (7) FZ-CZ--F7-T7, (8) FZ-CZ--F3-C3, (9) FZ-CZ--F8-T8, (10) FZ-CZ--F4-C4. Centralparietal sagittal coherences are represented in red; (11) T8-P8--T7-P7, (12) C4-P4--C3-P3, (13) C3-P3--T8-P8, (14) C4-P4--T7-P7, (15) C3-P3--T7-P7, (16)
C4-P4--T8-P8, (17) T7-P7--CZ-PZ, (18) C3-P3--CZ-PZ, (19) T8-P8--CZ-PZ, (20) C4-P4--CZ-PZ, parietal-occipital sagittal coherences are represented in
purple; (21) P4-O2--P3-O1. Intrahemispheric lateral coherences are represented in orange; (22) T7-C3--F7-F3, (23) P7-P3--F7-F3, (24) P7-P3--T7-C3, (25)
T8-C4--F8-F4, (26) P8-P4--F8-F4, (27) P8-P4--T8-C4.

mixed evidence regarding the inﬂuence of substance use
on the onset of psychosis45, and the potential for confounding introduced by the enrichment of substance use/
disorders within the COGA derived sample, we examined
models adjusted for the regular use of alcohol and nicotine, and ever use of cannabis on PRS-EEG coherence
associations. We next examined speciﬁc genetic variants
included in the PRS to determine whether any individual
SCZ loci are driving this ﬁnding. Note that 101 of 108 loci
reported by the PGC were available for analysis in the
COGA sample.
We examined similar models independently including
PRS for related conditions, BiP and MDD43,44, to determine the similarities and differences in developmental
trajectories of EEG coherence for polygenic inﬂuences
across all three conditions. Only the single most

signiﬁcant PRS were examined, selected on the basis of
the EEG coherence association ﬁndings. All analyses were
conducted in Matlab and were subject to an FDR correction for multiple testing; requiring p < 10–4 for signiﬁcant associations based on an FDR less than 0.01.

Results
We found that SCZ PRS were associated with increased
EEG coherence in the theta and alpha frequencies in
COGA participants. Findings for PRS based on the p <
0.05 threshold withstood a multiple test correction (FDR
< 0.010), with the majority of coherence pairs in these
frequency bands showing strong association with SCZ
PRS (effect sizes ranged from 0.15 to 0.21 with all
p-values < 10–4, Table 1; see also Fig. 2). We observed
signiﬁcant differences based on age and sex (Fig. 2 and
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Table 1 First quartile of association beta coefﬁcients and
p-values of SCZ PRS with high-alpha EEG coherence in
males and females ages 12–31 with −log10
transformation.
Ages 12–17

Ages 18–25

Ages 26–31

Male

Male

Male

Female

Female

Female

Frontal-central
sagittal

−log10
p-value

−log10
p-value

−log10
p-value

1

F8-T8--F7-T7

0.83

0.69

2.52

0.75

0.76

0.98

2

F4-C4--F3-C3

2.35

0.69

1.34

0.53

1.88

1.17

3

F3-C3--F8-T8

2.13

1.44

2.23

1.02

0.68

2.88

4

F4-C4--F7-T7

0.56

0.61

1.52

0.51

0.71

0.41

5

F3-C3--F7-T7

3.07

1.23

1.96

2.82

2.10

3.72

6

F4-C4--F8-T8

0.58

0.72

1.00

1.00

1.93

1.94

7

FZ-CZ--F7-T7

4.77

0.87

4.43

1.04

2.30

1.25

8

FZ-CZ--F3-C3

3.97

2.41

2.85

1.24

2.62

1.09

9

FZ-CZ--F8-T8

1.31

1.31

1.21

1.18

0.56

3.41

10

FZ-CZ--F4-C4

2.36

1.23

3.14

1.55

3.87

1.18

Central-parietal sagittal
11

T8-P8--T7-P7

3.17

0.70

3.97

0.80

2.01

0.87

12

C4-P4--C3-P3

3.33

1.29

4.50

0.79

3.61

0.44

13

C3-P3--T8-P8

3.13

1.03

2.22

0.91

1.81

1.14

14

C4-P4--T7-P7

4.14

0.90

4.62

0.99

2.47

0.52

15

C3-P3--T7-P7

4.47

0.64

4.77

2.45

1.89

1.49

16

C4-P4--T8-P8

3.20

1.98

2.77

2.70

1.59

1.61

17

T7-P7--CZ-PZ

3.09

1.17

5.15

1.54

2.87

1.12

18

C3-P3--CZ-PZ

2.52

1.62

5.18

1.35

4.97

1.62

19

T8-P8--CZ-PZ

1.77

0.91

2.10

1.19

0.93

0.57

20

C4-P4--CZ-PZ

2.64

1.64

4.12

1.17

3.32

1.32

3.09

5.38

1.22

2.60

1.29

Parietal-occipital sagittal
21

P4-O2--P3-O1

5.24

central-parietal (P7-P3 -- T7-C3, P8-P4 -- T8-C4,
T7-P7 -- CZ-PZ, C3-P3 -- CZ-PZ), as well as right
intrahemispheric (P8-P4--F8-F4, P8-P4--T8-C4) coherence pairs. Associations between PRS and high-alpha
coherence were less robustly associated among females,
with associations between PRS and fronto-central
(F3-C3 -- F7-T7, FZ-CZ -- F8-T8) coherence pairs only
observed at ages 24–26. Results are detailed in Table 1. In
PRS-EEG coherence association models including alcohol,
nicotine, and cannabis use frequency as covariates, results
were largely unchanged (see Supplemental material).
Of the 101 genome-wide associated SNPs examined,
male-only associations of alpha EEG coherence with
rs59979824 (an intergenic variant on chromosome 2) and
rs11740474 (GALNT10 variant on chromosome 5) withstood a multiple test correction (Fig. 3, Supplemental Fig.
3, and Supplemental Table 1); Fig. 3 displays the association of rs59979824 (panel A) and rs11740474 (panel B)
with high-alpha EEG coherence in males from ages
12–32. Associations of rs59979824 with high-alpha EEG
coherence were observed across several fronto-central
electrode pairs, with effects peaking between ages 14–24.
In contrast, the majority of associations observed between
rs11740474 and fronto-central high-alpha coherence
occurred between ages 25–31.
Signiﬁcant positive associations were observed among
PRS for SCZ, BiP and MDD (SCZ and MDD PRS correlations ranged from 0.2 to 0.4, whereas SCZ and BiP PRS
correlations were as high as 0.9). Both BiP and MDD PRS
were also associated with EEG coherence. For MDD PRS,
the most robust associations were observed with centralparietal high-alpha coherence in females ages 25 and
older and in central-temporal high-alpha coherence in
males ages 25 and older (Fig. 4 and Supplemental Table
2). For BiP PRS, the most robust associations were
observed with central-frontal (FZ-CZ—F3-C3) high-alpha
coherence in females ages 12–18 and central-parietal (P8P4--T8-C4) high-alpha coherence in males 12–18 (Fig. 5
and Supplemental Table 3).

Intrahemispheric lateral
22

T7-C3--F7-F3

0.66

0.84

2.48

0.99

4.87

2.50

23

P7-P3--F7-F3

1.56

0.56

1.64

0.94

1.87

0.89

24

P7-P3--T7-C3

4.93

0.97

2.99

1.31

3.55

1.83

25

T8-C4--F8-F4

1.14

1.86

2.73

1.31

2.37

1.19

26

P8-P4--F8-F4

4.36

0.44

3.64

1.55

1.79

1.68

27

P8-P4--T8-C4

6.42

0.76

4.56

2.01

2.43

2.16

All values in bold meet the false-discovery rate criterion of 10−4. Coherences
between bipolar electrode pairs are numbered from 1–27 and organized by
regions as illustrated in Fig. 1 and explained in its caption.

Supplemental Figs. 1–6). Among males, the most robust
associations were observed at ages 15–19 between PRS
and high-alpha parietal-occipital (P4-O2 -- P3-O1),

Discussion
We report the robust associations of polygenic risk
for SCZ with developmental trajectories of neural
connectivity among unaffected individuals: in particular, we observed that males with higher polygenic risk
for SCZ exhibit increased EEG coherence in the alpha
frequency band in posterior brain regions between the
ages of 15 and 19. Although the “disconnection
hypothesis”18 has been one of the main etiological
models of SCZ for decades and has been generally
supported46, empirical evidence has been somewhat
mixed, pointing to more complex abnormalities in the
connectivity pattern including both increases and
decreases of connectivity depending on speciﬁc
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Fig. 2 Association of SCZ PRS with interhemispheric and intrahemispheric high-alpha (9–12 Hz) EEG coherence networks in males (A) and
females (B) from ages 12–31. Age is represented on the x-axis and coherences are represented on the y-axis, with numbering 1–27 corresponding
to coherences between bipolar electrode pairs illustrated in Fig. 1. Regional divisions are marked with horizonal white grid lines: 1–10 anterior
(frontal-central); 11–21 posterior (central-parietal-occipital); 22–27 left and right/anterior and posterior intrahemispheric. Color values in the main
panels indicate levels of signiﬁcance (p-values on a negative log 10 scale) as indicated by the color bars on the right.

location, subjects’ state (e.g., during a task vs. in the
resting-state), and neuroimaging modality47–49. Findings from our study of increased connectivity correspond well to previous work demonstrating higher
resting-state alpha EEG coherence both within and
across hemispheres among individuals with SCZ and in
their relatives5. While increased connectivity observed
among individuals with higher SCZ PRS may seem
counterintuitive to many dysconnectivity hypotheses in
psychotic illness, several previous studies have found
similar patterns of increased connectivity among those
with SCZ and their relatives5,50–54. For example, Kam
et al.5 found that individuals with SCZ exhibited greater
connectivity, and emphasized that, as in our study, EEG
was recorded during rest as opposed to during a cognitive task. They suggest that this pattern of increased
neural synchronization may reﬂect network activity in
the resting-state that is less selectively organized among
individuals at risk for SCZ, consistent with suggestions
that SCZ may be associated with inefﬁcient neural
processing55–57.
Further, we found striking sex differences wherein
polygenic risk for SCZ was associated with increased
parietal-occipital and -central alpha coherence among

males ages 15–19, and with fronto-central alpha coherence among females ages 25–31, mapping onto key periods of risk for the onset of psychotic illness in each
group. Interestingly, this was in contrast to ﬁndings for
polygenic risk for MDD, where the most robust associations were observed with central-parietal alpha coherence
in both males and females at age 25, also mirroring the
later clinical onset of MDD. Findings from this study
support a century of theory positing SCZ as a neurodevelopmental disorder, with perturbations in brain development occurring well before the onset of symptoms. We
note however, that these PRS effects are subtle (R2 values
< 0.02). Findings also demonstrate the critical importance
of examining sex differences in neuropsychiatric PRSEEG coherence associations throughout development.
We observed important sex and developmental effects
in the association of two individual genome-wide signiﬁcant SCZ risk loci with high-alpha coherence; effects of
intergenic chromosome 2 variant rs59979824 were
observed among males 14–24, whereas the effect of
GALNT10 variant rs11740474 on chromosome 5 was
most robustly observed after age 25. rs59979824 has been
associated with SCZ in three independent studies32,58,59
and a fourth study that examined overlapping SCZ and
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Fig. 3 Associations of rs59979824 (top panel a) and rs11740474 (bottom panel b) with high-alpha EEG coherence in males from ages
12–31. Age is represented on the x-axis and coherences are represented on the y-axis, with numbering 1–27 corresponding to coherences between
bipolar electrode pairs illustrated in Fig. 1. Regional divisions are marked with horizontal white grid lines: 1–10 anterior (frontal-central); 11–21
posterior (central-parietal-occipital); 22–27 left and right intrahemispheric. Color values in the main panels indicate levels of signiﬁcance (p-values on
a negative log 10 scale) as indicated by the color bars on the right.

autism spectrum disorder (ASD) GWAS variants60. There
is some evidence, albeit weak, from the Braineac database
(http://www.braineac.org/) that rs59979824 is associated
with the expression of TMEFF2, which has also been
previously associated with SCZ61,62. Recent investigations
have suggested that TMEFF2 may modulate the level of
sarcosine (N-methylglycine) and therefore the activity of
the glycine transporter type I (GlyT1)61,62. One of the two
primary pharmacological possibilities for enhancing
function of the NMDA receptor relies on inhibiting the
glycine transporter type I (GlyT-1) with sarcosine, bitopertin (RG1678), or ALX-540763. Sarcosine has shown
promising early results in ameliorating cognitive and
negative symptoms in SCZ. GALNT10 variant rs11740474
has also been implicated in several previous studies of
SCZ32,58,59,64 and one study of ASD60.
Recent studies have shown that polygenic risk for SCZ
inﬂuences working memory in both individuals with23
and without SCZ24, with trend level evidence of the
relation of SCZ PRS with functional connectivity of
fronto-parietal network supporting numerical working
memory in healthy young adults24. Poorer performance
and slower processing speed on various cognitive tasks
have also been observed among individuals with SCZ65. A

recent study found that microstructural abnormalities in
the callosal white matter ﬁbers connecting bilateral temporal lobe cortices contribute to poor neuropsychological
performance and severe negative symptom in patients
with schizophrenia66. Taken together, there is strong
evidence that these cognitive deﬁcits are involved in risk
for SCZ. Fortunately, promising clinical trials of working
memory and processing speed training for individuals
with SCZ are underway67. However, further research is
needed to understand if genetic risk inﬂuences early
neural developmental factors to give rise to cognitive
deﬁcits, that may increase risk for SCZ.
SCZ, BiP and MDD are genetically correlated (rg =
0.34–0.70) suggesting pleiotropic effects of variants across
these three disorders. Despite the genetic correlations
consistently observed among these conditions, patterns of
associations with SCZ PRS differed markedly from those
observed for BiP and MDD PRS (Supplemental Fig. 4).
Whereas inﬂuences of SCZ PRS were observed only for
males aged 16–20 (Fig. 2), both BiP PRS and MDD PRS
had inﬂuences in both males and females, with BiP effects
appearing later in females, and MDD effects manifesting
in females after age 24 (Figs. 4–5). Additionally, SCZ PRS
effects are more widespread throughout the brain,
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Fig. 4 Association of depression PRS with interhemispheric and intrahemispheric high-alpha EEG coherence networks in males (A) and
females (B) from ages 12–31. Age is represented on the x-axis and coherences are represented on the y-axis, with numbering 1–27 corresponding
to coherences between bipolar electrode pairs illustrated in Fig. 1. Regional divisions are marked with horizontal white grid lines: 1–10 anterior
(frontal-central); 11–21 posterior (central-parietal-occipital); 22–27 left and right intrahemispheric. Color values in the main panels indicate levels of
signiﬁcance (p-values on a negative log 10 scale) as indicated by the color bars on the right.

impacting frontal, central, posterior, and both interhemispheric and intrahemispheric electrode pairs,
whereas effects of BiP and MDD PRS were largely interhemispheric and central-posterior. While some of these
observed effects are shared across all three conditions25,
the similarities and distinctions are in line with what is
known regarding the shared and unique genetic and
neural contributions to SCZ, BiP, and MDD.
The current study uncovered neurodevelopmental patterns of brain connectivity in adolescents and young
adults who did not have a clinical diagnosis of SCZ (or
BiP, MDD) but were at varying polygenic liability to SCZ.
We also demonstrated important sex and developmental
differences in these brain connectivity patterns. This is the
ﬁrst study to our knowledge that has linked neuropsychiatric PRS to developmental trajectories of brain
connectivity. The most notable strength of this study
includes the large genetic sample of males and females
assessed with repeated measures of connectivity
throughout adolescence and young adulthood—a key
neurodevelopmental period. However, we note that the
power to detect signiﬁcant associations with EEG coherence trajectories was impacted by the discovery GWAS

sample sizes, and the disorder-speciﬁc genetic architecture; that is, SCZ and BiP have greater heritability than
MDD and relatedly the discovery sample sizes for SCZ
GWAS are greater than sample sizes for BiP and MDD. In
addition, an important limitation of the current study is
that only EA individuals were included due to the majority
EA composition of these discovery GWAS, as crossancestry predictions have the potential to yield biased (or
confounded) estimates68. Future directions of this work
include cross-ancestry replication of these effects using
new results from the Genomic Psychiatry Cohort (GPC)69
and joint analyses of other SCZ cohorts with available
clinical data, especially as related to age at onset and
speciﬁc SCZ symptom clusters. Findings from this study
of unaffected individuals from the general population (i.e.,
in the absence of clinical features of SCZ or a family
history of SCZ) should be compared with patterns
observed in clinical samples of those with SCZ, BiP, and
MDD. In addition, EEG studies could be paired with fMRI
to combine the advantages of the superior spatial resolution of MRI and the superior temporal resolution of
EEG, to better understand ﬁndings from both modes of
measuring functional connectivity.
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Fig. 5 Association of bipolar disorder PRS with interhemispheric and intrahemispheric high-alpha EEG coherence networks in males (A)
and females (B) from ages 12–31. Age is represented on the x-axis and coherences are represented on the y-axis, with numbering 1–27
corresponding to coherences between bipolar electrode pairs illustrated in Fig. 1. Regional divisions are marked with horizontal white grid lines: 1–10
anterior (frontal-central); 11–21 posterior (central-parietal-occipital); 22–27 left and right intrahemispheric. Color values in the main panels indicate
levels of signiﬁcance (p-values on a negative log 10 scale) as indicated by the color bars on the right.
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